We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$448M
AUM Growth
+$27.4M
Cap. Flow
-$2.9M
Cap. Flow %
-0.65%
Top 10 Hldgs %
45.62%
Holding
194
New
3
Increased
20
Reduced
27
Closed
116

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$12.6M
2
ADP icon
Automatic Data Processing
ADP
+$12.1M
3
ANET icon
Arista Networks
ANET
+$6.37M
4
PCAR icon
PACCAR
PCAR
+$5.94M
5
ATVI
Activision Blizzard
ATVI
+$5.34M

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$7.61M
2
QCOM icon
Qualcomm
QCOM
+$7.59M
3
DHR icon
Danaher
DHR
+$7.02M
4
CMG icon
Chipotle Mexican Grill
CMG
+$5.41M
5
AAPL icon
Apple
AAPL
+$5.19M

Sector Composition

Rank Sector Weight
1 Healthcare 31.2%
2 Technology 22.61%
3 Financials 14.43%
4 Consumer Staples 13.46%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.82T
$30.7M 6.87%
236,554
-36,285
-13% -$5.19M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.06T
$26.4M 5.9%
85,537
-56
-0.1% -$16.6K
UNH icon
3
UnitedHealth
UNH
$384B
$22.5M 5.03%
42,430
-3,300
-7% -$1.75M
LLY icon
4
Eli Lilly
LLY
$1.03T
$20.1M 4.48%
54,830
+11,256
+26% +$3.99M
PEP icon
5
PepsiCo
PEP
$184B
$18.5M 4.12%
102,146
-400
-0.4% -$71.3K
V icon
6
Visa
V
$687B
$18.4M 4.12%
88,700
+62,266
+236% +$12.6M
JNJ icon
7
Johnson & Johnson
JNJ
$601B
$17.8M 3.98%
100,886
-9,160
-8% -$1.58M
MA icon
8
Mastercard
MA
$484B
$17.8M 3.97%
51,082
+58
+0.1% +$19.1K
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$122B
$16.1M 3.6%
55,740
-6,680
-11% -$2.04M
ORCL icon
10
Oracle
ORCL
$352B
$15.9M 3.55%
194,133
+18,200
+10% +$1.38M
PG icon
11
Procter & Gamble
PG
$347B
$14.7M 3.29%
97,277
-9,000
-8% -$1.26M
DHR icon
12
Danaher
DHR
$143B
$14.7M 3.29%
62,509
-30,287
-33% -$7.02M
ATO icon
13
Atmos Energy
ATO
$29.6B
$13.4M 3%
119,610
-340
-0.3% -$37.4K
CP icon
14
Canadian Pacific Kansas City
CP
$81.7B
$12.8M 2.87%
171,888
+35,700
+26% +$2.69M
ADP icon
15
Automatic Data Processing
ADP
$102B
$12.7M 2.83%
53,055
+49,421
+1,360% +$12.1M
MRK icon
16
Merck
MRK
$307B
$10.3M 2.3%
92,750
+22,300
+32% +$2.28M
PANW icon
17
Palo Alto Networks
PANW
$288B
$9.66M 2.16%
138,520
-1,280
-0.9% -$103K
COST icon
18
Costco
COST
$416B
$9.36M 2.09%
20,500
-8,950
-30% -$4.37M
MSFT icon
19
Microsoft
MSFT
$2.98T
$8.84M 1.98%
36,871
-20,610
-36% -$4.95M
BG icon
20
Bunge Global
BG
$23.4B
$8.73M 1.95%
87,500
REGN icon
21
Regeneron Pharmaceuticals
REGN
$70.7B
$8.43M 1.88%
11,690
LIN icon
22
Linde
LIN
$237B
$8.09M 1.81%
24,800
+8,000
+48% +$2.51M
TMO icon
23
Thermo Fisher Scientific
TMO
$196B
$6.74M 1.51%
12,237
-110
-0.9% -$58.3K
ANET icon
24
Arista Networks
ANET
$214B
$6.71M 1.5%
221,072
+206,800
+1,449% +$6.37M
CCI icon
25
Crown Castle
CCI
$33.9B
$6.23M 1.39%
45,950
-56,250
-55% -$7.61M

Similar funds

De Burlo Group's Q4 2022 Portfolio in Review

As of Q4 2022, De Burlo Group held 194 positions worth $448M, up 6.5% from $420M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

De Burlo Group's Q4 2022 filing shows 3 new, 20 increased, 27 reduced and 116 closed positions. Its largest new stake was PACCAR: 90,900 shares worth $6M. The largest sale was Crown Castle, an estimated $7.61M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • De Burlo Group's largest Q4 2022 buy was PACCAR: 90,900 shares worth $6M.
  • De Burlo Group added most to Visa in Q4 2022, an estimated $12.6M increase.
  • De Burlo Group's biggest Q4 2022 reduction was Crown Castle, cutting an estimated $7.61M.
  • De Burlo Group fully exited Qualcomm in Q4 2022, selling an estimated $7.59M.
  • De Burlo Group's ten largest holdings make up 46% of its $448M portfolio in Q4 2022.
  • De Burlo Group opened 3 new positions and closed 116 in Q4 2022.
  • De Burlo Group's portfolio value rose 6.5% quarter-over-quarter to $448M.

Based on De Burlo Group's 13F filing for Q4 2022, filed 14 Feb 2023.